GILD vs RHLD · P/E 18, rev $7.80B vs rev $462.1M
Gilead Sciences Inc (GILD) versus Resolute Holdings Management Inc. (RHLD) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Resolute Holdings Management Inc. (RHLD) is a specialty business services company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported RHLD revenue for 2025-12-31 was $462.1M. Net income was -$5.9M. Revenue was up 9.9% from 2024-12-31 to 2025-12-31. RHLD currently screens at market cap $286.6M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. RHLD currently screens at market cap $286.6M.
Not investment advice. Open the GILD and RHLD stock pages for the full models.
Not investment advice.